OR WAIT null SECS
Growth and Advancements in Fill/Finish
Leveraging automation advancements can help improve efficiency in aseptic processing.
Changes and Trends in the Outsourcing Landscape
Quality Considerations in Changing Excipient Providers
January 02, 2024
Clarivate has released its 2024 Drugs to Watch report, highlighting 13 therapies with great potential.
GSI shortages result from how hospitals buy GSI drugs, and the underinvestment in manufacturing operations that follow.
Reviewing regulatory documents, such as 483 forms and Warning Letters, can aid in determining a facility’s inspection readiness, says Siegfried Schmitt, vice president, Technical at Parexel.
Galbraith Laboratories, a Bureau Veritas Company, offers a full range of analytical services for pharma, from R&D to final release testing.
ROSS Mixers, a provider of US-designed and manufactured mixing equipment, offers a Trial Rental Program, giving process managers an opportunity to optimize R&D projects before committing to a substantial investment.
December 29, 2023
Clinician-Scientists are vital innovation spark plugs, accounting for 40% of Nobel awards in Physiology or Medicine, and two thirds of Big Pharma CSOs.
Through Syena, its oncology-focused product company, Replay will develop and manufacture T-cell receptor and natural killer cell therapies with the NIH and Miltenyi Biotec.
December 28, 2023
Is increasing molecular diversity pushing manufacturing ecosystem consolidation toward turnkey solutions?
Tome Bioscience is facilitating the transition in biology from the editing phase to the cut-and-paste phase.